Background: Developmental dysplasia of the hip (DDH) is a common condition, affecting 1% to 2% of full-term infants. The American Academy of Orthopaedic Surgeons (AAOS) and American Academy of Pediatrics have published guidelines detailing best practices for DDH screening and treatment. The purpose of this survey was to determine DDH treatment practices of pediatric orthopaedic surgeons in North America. Methods: We queried orthopaedic surgeon members of the Pediatric Orthopaedic Society of North America (POSNA) about referral patterns, treatment practices, and use of DDH guidelines. The survey included demographics, clinical scenarios, referrals patterns, and ultrasound practices. Results: Of the 1392 members of POSNA, we received 432 total responses and included 353 in statistical analyses. Results show that 68% (233/342) of surgeons practice in an institution that does not endorse a standard care pathway for DDH. Of surgeons who personally use a DDH care pathway, the AAOS guidelines were most cited (143/353, 41%). The majority (94%, 316/337) of surgeons do not believe that universal ultrasound screening should be adopted in the United States. Responses regarding ultrasound screening for "high risk" infants as outlined by AAOS varied based on risk factor. Many (57%, 200/353) surgeons have performed initial evaluations for patients over 12 months of age. While 80% (260/327) of orthopaedic surgeons believe that primary care providers are referring patients appropriately, only 57% (183/323) believe that primary care providers are ordering imaging studies appropriately. Conclusions: Results from this survey of POSNA membership indicate an opportunity to better distribute and implement DDH guidelines. In addition, the implementation of a care map with a focus on standard referral and imaging practices could improve the care of patients with DDH by: (1) reducing the total cost of care, (2) increasing the use of appropriate imaging, (3) increasing timely referral for DDH care, and (4) reducing the presentation rate of walking age DDH patients. Level of Evidence: The level of evidence rating for this surveybased study is level IV.
D evelopmental dysplasia of the hip (DDH) is a common congenital defect affecting 1% to 2% of newborns worldwide. The severity of DDH can range from mild acetabular dysplasia to a completely dislocated and irreducible hip. These hip abnormalities are often detectable by physical examination or ultrasound soon after birth. DDH may be a component of systemic disorders but occurs most often in otherwise healthy infants. 1 Late-diagnosed (6 months or older) DDH is associated with an increased need for corrective surgeries and early onset of osteoarthritis. 2 Despite the fact that DDH is common, there remains controversy regarding best screening practices. 2, 3 In their most recent report on DDH, the United States Preventive Services Task Force (USPSTF) concluded that there was insufficient evidence to recommend routine DDH screening. 3 However, organizations such as American Academy of Pediatrics (AAP) and American Academy of Orthopaedic Surgeons (AAOS) advocate for universal screening by physical examination and selective ultrasonography, 1,3-6 the screening method most commonly used in North America.
Other countries have addressed late-diagnosed DDH by instituting universal ultrasound screening. Recent meta-analyses have failed to find evidence supporting the use of universal ultrasound screening, as it may result in increased treatment without evidence for a decrease in late-diagnosed DDH or corrective surgery. 7 There is also concern that increased treatment may lead to higher rates of iatrogenic complications [namely avascular necrosis (AVN)]. 2, 5 Reducing variation in health care is desirable when possible, 8 and the use of evidence-based clinical practice guidelines and appropriate utilization criteria may reduce variation, especially in cases in which clear evidence exists to guide care. 8, 9 Implementing a universal care map for DDH is nearly impossible due to a lack of consensus about proper screening and global disparities in health resources. 7 Recently, the AAP and AAOS tried to summarize the literature and provide opportunities to standardize DDH care and reduce variation.
The purpose of this study was to obtain a better understanding of providers' decision-making processes regarding DDH treatment in otherwise healthy infants by conducting a survey of pediatric orthopaedic surgeons in North America.
METHODS
An online survey (Appendix I, Supplemental Digital Content 1, http://links.lww.com/BPO/A262) was prepared and distributed to members of the Pediatric Orthopaedic Society of North America (POSNA) via email. Study data were collected and managed using Research Electronic Data Capture (REDCap) tools. 10 The survey consisted of 5 sections: Physician and Patient Demographics, Referrals and Ultrasound, DDH Management, and Clinical Examples of Hip Abnormalities. We aimed to clarify the use of AAOS and AAP DDH guidelines, patterns of referrals to orthopaedic specialists, and perspectives on ultrasound use in DDH screening. 11 For continuous variables, the Kruskal-Wallis test was utilized for comparison of care pathways. For categorical variables, Fisher's exact test was performed. All tests were 2-sided with a significance level of 0.05, and all analysis was performed in RStudio.
RESULTS
In total, 432 (31.0%) of the approximate 1392 members of POSNA responded to the survey, and responses from 353 of these physicians were used in statistical analysis. Respondents who practiced outside of the United States, Canada, Mexico, or Puerto Rico were excluded. The geographic distribution of survey participants is shown in Figure 1 .
Physician and Patient Demographics
The vast majority of respondents were fellowship-trained and practiced in an academic setting. Most (84.1%, 296/352) survey participants reported seeing DDH patients at least once per month. Respondents have been in practice for a median of 18 years (interquartile range, 7 to 27, Table 1 ).
Referrals and Ultrasound
The survey asked orthopaedic surgeons a series of questions to better understand referral patterns and diagnostic practices. Most surgeons (79.5%, 260/327) believed that primary care providers (PCPs) are referring patients appropriately, but over-referral remains a complaint from those who disagree (67.2%, 45/67). Most (96.3%, 314/326) surgeons ordered ultrasounds for DDH patients and 89.8% (293/326) agreed with the majority of ultrasound interpretations (Tables 2 and 3 ).
DDH Management
Most surgeons personally used DDH care maps or guidelines for patient management (81.3%, 287/353), with AAOS guidelines being the most frequently cited (143/353, 40.5%). However, most (68.1%, 233/342) surgeons responded that their institution does not formally endorse guidelines for DDH (Table 4 ).
Clinical Examples of Hip Abnormalities
Surgeons were asked to select the next step(s) they would take in the following clinical scenarios: isolated positive Barlow in a child below 4 weeks of age, isolated positive Ortolani in a child below 4 weeks of age, limited hip abduction in children both below 4 months and above 4 months of age, and mild dysplasia on ultrasound without physical examination findings in a child 3 months of age (Table 5 ).
DISCUSSION
This study identified several key findings regarding DDH care patterns in North America. The majority of respondents continue to see DDH in patients older than 1 year of age ( Table 2 ). In addition, many surgeons still report over-referral of patients with suspected DDH from PCPs and believe that imaging studies are not being ordered appropriately. Importantly, most institutions do not endorse formal DDH care guidelines or pathways ( Table 4 ). The development of standard care processes may impact each of these findings by providing guidelines for PCPs who care for these patients during the first stage of evaluation and referral. Some health systems, such as St Luke's Health System in Boise, ID, have implemented a DDH care map to guide evaluation, management, imaging, and referral recommendations for PCPs ( Fig. 2) . These "care maps" are based upon the AAOS 2014 Evidence Based Clinical Practice Guideline and are designed to reduce variation in care when possible and to increase the quality and value of care. 11 Given that 56.7% of respondents have seen a child referred for initial DDH evaluation at an age of 12 months or older, late-diagnosed DDH remains a problem in North America. Earlier diagnosis and treatment are essential to avoiding complications such as malalignment, antalgic gait, decreased strength, and early osteoarthritis requiring arthroplasty. 12 In fact, up to one third of hip arthroplasty in patients under age 60 may be secondary to DDH, and in 1 recent study, the average age of hip arthroplasty for patients with DDH was found to be 42. 13, 14 However, despite extensive literature, there is no consensus about the best way to detect and treat hip dysplasia, 15 undoubtedly contributing to missed cases.
Physical Examination
Despite the USPSTF's 2006 recommendation, 5 99.1% (336/339) of surveyed physicians believe that infants should be screened with the Ortolani and Barlow maneuvers until 3 months of age. The American Academy of Family Physicians (AAFP) and AAP emphasize the diagnostic value of the Ortolani maneuver over the Barlow maneuver in young infants, and recommend observation rather than treatment for minor hip abnormalities. 1, 16 Many respondents chose to start abduction bracing for an isolated Ortolani positive hip (278/353, 78.8%) in accordance with AAP guidelines. However, there seems to be a propensity for overtreatment of isolated Barlow positive hips. Over half (52.4%, 185/353) of physicians chose to start abduction bracing for an isolated Barlow positive hip in a child under 4 weeks of age, when continued observation is typically the recommended course of action. 1 The AAFP and AAP both recommend considering referral on the basis of caregiver concern, 1,16 which may contribute to the over-referral reported by 67.2% (45/67) of surgeons who do not believe that primary care physicians are referring patients appropriately. In addition, orthopaedists and governing medical bodies express distaste of the term "hip click." 1, 4 It remains difficult to corroborate the surveyed sense of over-referral with the high number of late-presenting DDH cases.
How to "Select" for Selective Ultrasound, Radiography
The clinical examination is a foundation of DDH prevention, but its specificity and sensitivity vary and can be highly dependent on examiner experience. A 15-year longitudinal observational study found lower sensitivity, equivalent specificity, and lower positive predictive value for physical examination versus ultrasound screening. 17 However, studies have also reported somewhat poor validity and reliability of DDH ultrasound. 18 An estimated 15% to 25% of infants with DDH have known risk factors, 19 although a recent meta-analysis placed the relative risk for DDH related to breech presentation, family history, and female sex to be 3.5, 1.4, and 2.5, respectively. 4, 20 Organizations such as AAOS and AAP suggest imaging to evaluate at-risk infants with clinically stable hips before the age of 6 months. 1, 4 Ultrasound should not be performed before 2 weeks of age because of the laxity of newborns' hips and the subsequent higher rate of false positives. 6 Because the majority of newborn hip abnormalities resolve spontaneously, possible over-treatment remains a concern with hip abnormalities in young infants. 21 Most surgeons (83.6%, 295/353) identified breech position as a risk factor for which they would order an ultrasound regardless of physical examination findings, and 62.9% (222/ 353) of physicians indicated that they would do so for patients with a family history of hip dysplasia (Table 4 ). Studies corroborate this recommendation, demonstrating an increased rate of hip osteoarthritis in families with high rates of DDH due to undiagnosed acetabular dysplasia, 22 as well as an established familial inheritance of such abnormalities. 23 Incorrect swaddling was identified as an important risk factor for DDH by 5 pediatric organizations, but was only chosen as a risk factor warranting ultrasound by 7.9% of respondents (Table 4) . 1 This risk factor may be particularly important in certain cultures that practice tight infant swaddling. Female sex was seen as a risk factor warranting ultrasound by only 9.8% of responding physicians. Although some physicians wrote-in twin gestation, torticollis, foot abnormalities, and oligohydramnios as risk factors warranting ultrasound, there is no evidence that these individual factors increase risk for DDH. 24 In North America, ultrasound is vital for DDH diagnosis-reflected by the 96.3% of orthopaedic surgeons (314/326) who order ultrasounds for DDH patients. The AAOS continues to recommend against universal ultrasound screening, 4 although a study recently completed in the United Kingdom posits that universal screening can produce better treatment outcomes. 25 Likewise, universal DDH screening markedly decreased the number of infants requiring splint treatments by 50% in Austria. 26 Conversely, a Norwegian trial found no significant difference in the number of late-diagnosed DDH cases with universal ultrasound when compared with physical examination alone. 27 However, both the associated risk for AVN 2 and treatment rates are much higher in populations where universal screening is used, and costs for the health systems are not insignificant. 26 Overall, 93.8% (316/337) of surveyed physicians were against the adoption of universal ultrasound screening in North America.
Some surgeons (11.0%, 39/353) reported that they would order a pelvic radiograph for an infant younger The majority of physicians would elect to begin bracing treatment for a 3-month-old patient with mild dysplasia on ultrasound without physical examination findings, while AAP and AAOS recommend observation.
*Physicians were able to select more than one option, resulting in total percentage > 100%.
†Surgery may be recommended if over age 18 months in the setting of advanced disease.
|The AAOS and AAP recommend following this course of action. ✗The AAOS and AAP recommend against this course of action. Blank spaces: There are no guidelines specifically addressing this option. AAOS indicates American Academy of Orthopaedic Surgeons; AAP, American Academy of Pediatrics; US, ultrasound. ultrasound abnormalities worsen or physical examination findings present. 1, 4 However, 58.4% of physicians would elect to begin bracing treatment for a 3-month-old patient with mild dysplasia on ultrasound without physical examination findings. Bracing treatment is recommended for clinically unstable hips at any age, although a delay in treatment of 2 to 9 weeks (postnewborn examination) did not seem to affect outcomes. 1, 29 The vast majority of physicians elected to begin bracing in Ortolani positive hips (below 4 wk of age) and most chose to monitor limited hip abduction (above 4 mo of age) with a pelvic radiograph, which are decisions within current guidelines.
Most surveyed clinicians (91.2%) reported they would discontinue a splint or harness after 2 to 4 weeks of unsuccessful use, a decision in agreement with the AAP's recommendation. 1 However, 1 study examining the use of the Pavlik harness on patients with late-diagnosed DDH reported a mean time to stable reduction of 6 weeks, indicating that late-diagnosed DDH may require longer treatment times. 30 This study also reported a 15% incidence of AVN. 1, 30 Open surgery is not recommended until 18 months of age, 1 and no surveyed physician stated that they would initially recommend surgery for the given clinical scenarios.
Limitations
As with any survey, questions are open to interpretation and given that participants were asked to answer questions regarding their past practice experience, recall bias may be present. Although many clinical practice questions gave the option of choosing multiple "next steps," it is unknown if physicians chose all steps they would take versus a single next step. Lastly, meta-analyses indicate that most DDH literature is considered "weak" evidence, so the guidelines referenced throughout this manuscript may not provide optimal management methods.
CONCLUSIONS
Results from this survey indicate that orthopaedic surgeons generally practice within the AAOS and AAP guidelines for DDH management. However, there is low adoption of "institutionally-endorsed" care pathways and guidelines. Our most striking result was the large proportion of orthopaedists (56.7%) who have seen patients older than 12 months for initial DDH evaluation. Over 20% of surgeons do not believe that PCPs are referring patients appropriately and 37% do not believe that imaging studies are being ordered appropriately. There is also a high proportion of physicians who would elect to start treatment for isolated Barlow positive hips (below 4 wk of age) as well as for hips with mild dysplasia on ultrasound without signs of clinical instability (3 months of age), neither of which are recommended. Residual uncertainty remains regarding the importance of DDH risk factors-a problem that has not been remedied in guidelines.
This survey revealed that, although most orthopaedic surgeons agree on DDH treatment and management, discrepancies still exist. Because of the large body of often conflicting literature, it can be difficult to ascertain the "correct" management strategy. The implementation of a care map focused on standard referral and imaging practices could greatly improve the care of patients with DDH by reducing costs of care, increasing the use of appropriate imaging, increasing timely referral for DDH care, and reducing the presentation rate of walking age DDH patients.
